Skip to Content
You are currently on the new version of our website. Access the old version .

Cancers, Volume 13, Issue 12

2021 June-2 - 250 articles

Cover Story: Up to one third of all breast cancers are classified as the aggressive HER2-positive subtype, which is associated with a higher risk of recurrence compared to HER2-negative breast cancers. The HER2 hyperactivity associated with this subtype drives tumor growth by up-regulation of mTOR pathways and metabolic adaptation. Combination therapies that simultaneously target HER2 and mTOR improve clinical outcomes compared with HER2 inhibition alone. Drugs that mimic glucose deprivation in HER2-positive breast cancer patients have not been evaluated; however, preclinical studies have shown that the growth of HER2-positive breast tumors is reduced in response to combining the glycolytic inhibitor 2-DG with mTOR inhibitors. Here, we review the role of mTOR, glycolysis, and signaling mechanisms in HER2-positive breast cancer. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (250)

  • Reply
  • Open Access
8 Citations
3,245 Views
5 Pages

Reply to Orlhac, F.; Buvat, I. Comment on “Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features’ Stability with and without ComBat Harmonization. Cancers 2021, 13, 1848”

  • Abdalla Ibrahim,
  • Turkey Refaee,
  • Sergey Primakov,
  • Bruno Barufaldi,
  • Raymond J. Acciavatti,
  • Renée W. Y. Granzier,
  • Roland Hustinx,
  • Felix M. Mottaghy,
  • Henry C. Woodruff and
  • Andrew D. A. Maidment
  • + 2 authors

21 June 2021

We would like to thank Orlhac and Buvat [...]

  • Article
  • Open Access
26 Citations
17,866 Views
14 Pages

Are Borrmann’s Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study

  • Cristina Díaz del Arco,
  • Luis Ortega Medina,
  • Lourdes Estrada Muñoz,
  • Elena Molina Roldán,
  • M. Ángeles Cerón Nieto,
  • Soledad García Gómez de las Heras and
  • M. Jesús Fernández Aceñero

21 June 2021

Most studies on the clinicopathological impact of Borrmann classification for gastric cancer (GC) have been performed in Asian patients with type IV tumors, and immunohistochemical features of Borrmann types have scarcely been analyzed. We assessed t...

  • Review
  • Open Access
14 Citations
4,516 Views
16 Pages

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy

  • Frank J. Borm,
  • Jasper Smit,
  • Daniela E. Oprea-Lager,
  • Maurits Wondergem,
  • John B. A. G. Haanen,
  • Egbert F. Smit and
  • Adrianus J. de Langen

21 June 2021

In multiple malignancies, checkpoint inhibitor therapy has an established role in the first-line treatment setting. However, only a subset of patients benefit from checkpoint inhibition, and as a result, the field of biomarker research is active. Mol...

  • Article
  • Open Access
9 Citations
4,883 Views
15 Pages

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia

  • Raquel Delgado,
  • Karoline Kielbassa,
  • Johanna ter Burg,
  • Christian Klein,
  • Christine Trumpfheller,
  • Koen de Heer,
  • Arnon P. Kater and
  • Eric Eldering

21 June 2021

Objectives: Chronic lymphocytic leukemia (CLL) is a common form of leukemia with a heterogeneous clinical course that remains incurable due to the development of therapy resistance. In lymph node proliferation centers, signals from the microenvironme...

  • Review
  • Open Access
17 Citations
6,121 Views
20 Pages

Ca2+ Signaling and Its Potential Targeting in Pancreatic Ductal Carcinoma

  • Louay Bettaieb,
  • Maxime Brulé,
  • Axel Chomy,
  • Mel Diedro,
  • Malory Fruit,
  • Eloise Happernegg,
  • Leila Heni,
  • Anaïs Horochowska,
  • Mahya Housseini and
  • V’yacheslav Lehen’kyi
  • + 11 authors

21 June 2021

Pancreatic cancer (PC) is a major cause of cancer-associated mortality in Western countries (and estimated to be the second cause of cancer deaths by 2030). The main form of PC is pancreatic adenocarcinoma, which is the fourth most common cause of ca...

  • Review
  • Open Access
15 Citations
9,114 Views
18 Pages

Review of PP2A Tumor Biology and Antitumor Effects of PP2A Inhibitor LB100 in the Nervous System

  • Jean-Paul Bryant,
  • Adam Levy,
  • John Heiss and
  • Yeshavanth Kumar Banasavadi-Siddegowda

21 June 2021

Protein phosphatase 2A (PP2A) is a ubiquitous serine/threonine phosphatase implicated in a wide variety of regulatory cellular functions. PP2A is abundant in the mammalian nervous system, and dysregulation of its cellular functions is associated with...

  • Article
  • Open Access
15 Citations
3,451 Views
15 Pages

Electrochemotherapy with Bleomycin Enhances Radiosensitivity of Uveal Melanomas: First In Vitro Results in 3D Cultures of Primary Uveal Melanoma Cell Lines

  • Miltiadis Fiorentzis,
  • Ekaterina A. Sokolenko,
  • Nikolaos E. Bechrakis,
  • Saskia Ting,
  • Kurt W. Schmid,
  • Ali Sak,
  • Martin Stuschke,
  • Berthold Seitz and
  • Utta Berchner-Pfannschmidt

21 June 2021

Electrochemotherapy (ECT) is emerging as a complementary treatment modality for local tumor control in various cancer entities. Irradiation is an established therapeutic option for oncologic patients, which is commonly combined with chemotherapy due...

  • Article
  • Open Access
15 Citations
3,919 Views
17 Pages

The Challenge of Choosing the Best Classification Method in Radiomic Analyses: Recommendations and Applications to Lung Cancer CT Images

  • Federica Corso,
  • Giulia Tini,
  • Giuliana Lo Presti,
  • Noemi Garau,
  • Simone Pietro De Angelis,
  • Federica Bellerba,
  • Lisa Rinaldi,
  • Francesca Botta,
  • Stefania Rizzo and
  • Sara Raimondi
  • + 8 authors

21 June 2021

Radiomics uses high-dimensional sets of imaging features to predict biological characteristics of tumors and clinical outcomes. The choice of the algorithm used to analyze radiomic features and perform predictions has a high impact on the results, th...

  • Article
  • Open Access
4 Citations
3,076 Views
16 Pages

Hematopoietic Stem Cell Transplantation-Associated Neurological Complications and Their Brain MR Imaging Findings in a Pediatric Population

  • Hyewon Shin,
  • Mi-Sun Yum,
  • Min-Jee Kim,
  • Jin Kyung Suh,
  • Ho Joon Im,
  • Hyery Kim,
  • Kyung-Nam Koh and
  • Tae-Sung Ko

21 June 2021

Purpose: To determine the prognostic indicators for hematopoietic stem cell transplantation (HSCT)-associated neurological complications, the clinical characteristics and brain magnetic resonance imaging (MRI) lesions in pediatric HSCT recipients wer...

  • Article
  • Open Access
8 Citations
3,876 Views
15 Pages

B-Helper Neutrophils in Regional Lymph Nodes Correlate with Improved Prognosis in Patients with Head and Neck Cancer

  • Ekaterina Pylaeva,
  • Irem Ozel,
  • Anthony Squire,
  • Ilona Spyra,
  • Charlotte Wallner,
  • Magdalena Korek,
  • Georg Korschunow,
  • Maksim Domnich,
  • Elena Siakaeva and
  • Jadwiga Jablonska
  • + 4 authors

21 June 2021

The role of neutrophils during cancer formation and elimination is diverse. Here, for the first time, we investigate neutrophil helper cells (NBH), their influence on B cell activity in the regional lymph nodes (RLN) of head-and-neck cancer patients...

  • Review
  • Open Access
35 Citations
6,646 Views
23 Pages

Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art

  • Carmelo Laface,
  • Mariarita Laforgia,
  • Pasquale Molinari,
  • Ippazio Ugenti,
  • Cosmo Damiano Gadaleta,
  • Camillo Porta and
  • Girolamo Ranieri

21 June 2021

Liver functional failure is one of the leading causes of cancer-related death. Primary liver tumors grow up mainly in the liver, and thus happens for liver metastases deriving from other organs having a lower burden of disease at the primary site. Sy...

  • Review
  • Open Access
31 Citations
5,224 Views
13 Pages

21 June 2021

Cancer metabolism involves different changes at a cellular level, and altered metabolic pathways have been demonstrated to be heavily involved in tumorigenesis and invasiveness. A crucial role for oxidative stress in cancer initiation and progression...

  • Article
  • Open Access
42 Citations
5,236 Views
10 Pages

Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function

  • Florian Rosar,
  • Niklas Kochems,
  • Mark Bartholomä,
  • Stephan Maus,
  • Tobias Stemler,
  • Johannes Linxweiler,
  • Fadi Khreish and
  • Samer Ezziddin

21 June 2021

Background: Radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA) is an effective antitumor-treatment in metastatic castration-resistant prostate carcinoma (mCRPC). Concerns of potential nephrotoxicity are based on renal tubul...

  • Article
  • Open Access
20 Citations
5,292 Views
33 Pages

A Comprehensive Bioinformatics Analysis of Notch Pathways in Bladder Cancer

  • Chuan Zhang,
  • Mandy Berndt-Paetz and
  • Jochen Neuhaus

21 June 2021

Background: A hallmark of Notch signaling is its variable role in tumor biology, ranging from tumor-suppressive to oncogenic effects. Until now, the mechanisms and functions of Notch pathways in bladder cancer (BCa) are still unclear. Methods: We use...

  • Article
  • Open Access
9 Citations
4,624 Views
14 Pages

21 June 2021

Objectives: Patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) ultimately acquire resistance to EGFR tyrosine kinase inhibitors (TKIs) during treatment. In 5–22% of these patients, resistance is mediated b...

  • Article
  • Open Access
1 Citations
3,837 Views
12 Pages

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma

  • I-Chen Wu,
  • Yao-Kuang Wang,
  • Yi-Hsun Chen,
  • Chun-Chieh Wu,
  • Meng-Chieh Wu,
  • Wei-Chung Chen,
  • Wen-Lun Wang,
  • Hung-Shun Lin,
  • Chou-Cheng Chen and
  • Ming-Tsang Wu
  • + 2 authors

21 June 2021

Esophageal squamous cell carcinoma (ESCC) is a highly aggressive tumor known to have locally advanced and metastatic features which cause a dismal prognosis. We sought to determine whether elafin, a non-invasive and secretory small-molecule marker, c...

  • Article
  • Open Access
14 Citations
4,339 Views
19 Pages

Gender-Specific Efficacy Revealed by Head-to-Head Comparison of Pasireotide and Octreotide in a Representative In Vivo Model of Nonfunctioning Pituitary Tumors

  • Sebastian Gulde,
  • Tobias Wiedemann,
  • Mathias Schillmaier,
  • Isabel Valença,
  • Amelie Lupp,
  • Katja Steiger,
  • Hsi-Yu Yen,
  • Stephen Bäuerle,
  • Johannes Notni and
  • Natalia S. Pellegata
  • + 5 authors

21 June 2021

Invasive nonfunctioning pituitary tumors (NFPTs) are non-resectable neoplasms associated with frequent relapse and significant comorbidities. Current treatments, including somatostatin receptor 2 (SSTR2)-directed somatostatin analogs (SSAs), often fa...

  • Article
  • Open Access
34 Citations
5,381 Views
12 Pages

Deep Learning with Quantitative Features of Magnetic Resonance Images to Predict Biochemical Recurrence of Radical Prostatectomy: A Multi-Center Study

  • Ye Yan,
  • Lizhi Shao,
  • Zhenyu Liu,
  • Wei He,
  • Guanyu Yang,
  • Jiangang Liu,
  • Haizhui Xia,
  • Yuting Zhang,
  • Huiying Chen and
  • Jian Lu
  • + 8 authors

21 June 2021

Biochemical recurrence (BCR) occurs in up to 27% of patients after radical prostatectomy (RP) and often compromises oncologic survival. To determine whether imaging signatures on clinical prostate magnetic resonance imaging (MRI) could noninvasively...

  • Article
  • Open Access
21 Citations
4,825 Views
15 Pages

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma

  • Lisa Kinget,
  • Eduard Roussel,
  • Annelies Verbiest,
  • Maarten Albersen,
  • Cristina Rodríguez-Antona,
  • Osvaldo Graña-Castro,
  • Lucía Inglada-Pérez,
  • Jessica Zucman-Rossi,
  • Gabrielle Couchy and
  • Benoit Beuselinck
  • + 4 authors

21 June 2021

Metastatic clear-cell renal cell carcinoma (m-ccRCC) is characterized by increased hypoxia-induced factor (HIF)-2α and vascular endothelial growth factor receptor (VEGFR)-dependent angiogenesis through loss of function of the von Hippel–Lindau protei...

  • Review
  • Open Access
25 Citations
6,811 Views
27 Pages

An Updated Understanding of the Role of YAP in Driving Oncogenic Responses

  • Giampaolo Morciano,
  • Bianca Vezzani,
  • Sonia Missiroli,
  • Caterina Boncompagni,
  • Paolo Pinton and
  • Carlotta Giorgi

21 June 2021

Yes-associated protein (YAP) has emerged as a key component in cancer signaling and is considered a potent oncogene. As such, nuclear YAP participates in complex and only partially understood molecular cascades that are responsible for the oncogenic...

  • Article
  • Open Access
5 Citations
3,522 Views
15 Pages

Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study

  • Marina Berger,
  • Andrea Thueringer,
  • Doritt Franz,
  • Nadia Dandachi,
  • Emina Talakić,
  • Georg Richtig,
  • Erika Richtig,
  • Peter Michael Rohrer,
  • Lukas Koch and
  • Ariane Aigelsreiter
  • + 7 authors

21 June 2021

We prospectively performed a longitudinal analysis of circulating tumor DNA (ctDNA) from 149 plasma samples and CT scans in Stage III and IV metastatic melanoma patients (n = 20) treated with targeted agents or immunotherapy using two custom next-gen...

  • Article
  • Open Access
7 Citations
3,156 Views
17 Pages

T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker

  • Magda Zanelli,
  • Giuseppe G. Loscocco,
  • Elena Sabattini,
  • Maurizio Zizzo,
  • Francesca Sanguedolce,
  • Luigi Panico,
  • Daniela Fanni,
  • Raffaella Santi,
  • Cecilia Caprera and
  • Stefano Ascani
  • + 7 authors

21 June 2021

Background: Rarely, T-lymphoblastic lymphoma (T-LBL) may develop in the setting of myeloid/lymphoid neoplasms with eosinophilia (M/LNs-Eo), a group of diseases with gene fusion resulting in overexpression of an aberrant tyrosine kinase or cytokine re...

  • Review
  • Open Access
31 Citations
5,806 Views
24 Pages

Perspectives on Hypoxia Signaling in Tumor Stroma

  • Yuqing Zhang,
  • Morgan Coleman and
  • Rolf A. Brekken

20 June 2021

Hypoxia is a well-known characteristic of solid tumors that contributes to tumor progression and metastasis. Oxygen deprivation due to high demand of proliferating cancer cells and standard of care therapies induce hypoxia. Hypoxia signaling, mainly...

  • Review
  • Open Access
15 Citations
5,122 Views
12 Pages

20 June 2021

Despite significant innovations in lung cancer treatment, such as targeted therapy and immunotherapy, lung cancer is still the principal cause of cancer-associated death. Novel strategies to overcome drug resistance and inhibit metastasis in cancer a...

  • Article
  • Open Access
8 Citations
4,066 Views
18 Pages

Global Alternative Splicing Defects in Human Breast Cancer Cells

  • Jagyeong Oh,
  • Davide Pradella,
  • Yoonseong Kim,
  • Changwei Shao,
  • Hairi Li,
  • Namjeong Choi,
  • Jiyeon Ha,
  • Anna Di Matteo,
  • Xiang-Dong Fu and
  • Haihong Shen
  • + 2 authors

20 June 2021

Breast cancer is the most frequently occurred cancer type and the second cause of death in women worldwide. Alternative splicing (AS) is the process that generates more than one mRNA isoform from a single gene, and it plays a major role in expanding...

  • Article
  • Open Access
7 Citations
5,532 Views
20 Pages

Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma

  • Margaux Lejeune,
  • Elodie Duray,
  • Matthias Peipp,
  • Béatrice Clémenceau,
  • Frédéric Baron,
  • Yves Beguin and
  • Jo Caers

20 June 2021

Multiple myeloma (MM) is an incurable cancer characterized by the proliferation and accumulation of monoclonal plasma cells in the bone marrow. The monoclonal anti-CD38 daratumumab has taken a central place in the different treatment regimens for new...

  • Review
  • Open Access
18 Citations
7,134 Views
26 Pages

Engineered EV-Mimetic Nanoparticles as Therapeutic Delivery Vehicles for High-Grade Serous Ovarian Cancer

  • Amal A. Al-Dossary,
  • Essam A. Tawfik,
  • Adaugo C. Isichei,
  • Xin Sun,
  • Jiahe Li,
  • Abdullah A. Alshehri,
  • Munther Alomari,
  • Fahad A. Almughem,
  • Ahmad M. Aldossary and
  • Abdulaziz M. Almalik
  • + 1 author

20 June 2021

High-grade serous ovarian cancer (HGSOC) is the most lethal gynecological malignancy among women. Several obstacles impede the early diagnosis and effective treatment options for ovarian cancer (OC) patients, which most importantly include the develo...

  • Article
  • Open Access
29 Citations
3,842 Views
14 Pages

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience

  • Nethanel Asher,
  • Noa Israeli-Weller,
  • Ronnie Shapira-Frommer,
  • Guy Ben-Betzalel,
  • Jacob Schachter,
  • Tomer Meirson and
  • Gal Markel

20 June 2021

Background: Immunotherapy has revolutionized outcomes for melanoma patients, by significantly prolonging survival and probably even curing a fraction of metastatic patients. In daily practice, treatment for responding patients is often discontinued d...

  • Review
  • Open Access
22 Citations
5,210 Views
13 Pages

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma

  • Hans-Georg Wirsching,
  • Michael Weller,
  • Stefan Balabanov and
  • Patrick Roth

20 June 2021

This review article outlines the current development of emerging treatment strategies for primary central nervous system lymphoma, a rare brain tumor with, thus far, limited therapeutic options. Small molecule targeted tyrosine kinase inhibitors, imm...

  • Review
  • Open Access
45 Citations
6,341 Views
22 Pages

The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma

  • Yi-Te Lee,
  • Benjamin V. Tran,
  • Jasmine J. Wang,
  • Icy Y. Liang,
  • Sungyong You,
  • Yazhen Zhu,
  • Vatche G. Agopian,
  • Hsian-Rong Tseng and
  • Ju Dong Yang

20 June 2021

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and one of the leading causes of cancer-related death worldwide. Despite the improvements in surveillance and treatment, the prognosis of HCC remains poor. Extracellular vesic...

  • Systematic Review
  • Open Access
15 Citations
4,903 Views
20 Pages

The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis

  • Yuh Cai Chia,
  • Md Asiful Islam,
  • Phil Hider,
  • Peng Yeong Woon,
  • Muhammad Farid Johan,
  • Rosline Hassan and
  • Marini Ramli

20 June 2021

Multiple recurrent somatic mutations have recently been identified in association with myeloproliferative neoplasms (MPN). This meta-analysis aims to assess the pooled prevalence of TET2 gene mutations among patients with MPN. Six databases (PubMed,...

  • Article
  • Open Access
19 Citations
3,874 Views
18 Pages

Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases

  • Guido Costa,
  • Lara Cavinato,
  • Chiara Masci,
  • Francesco Fiz,
  • Martina Sollini,
  • Letterio Salvatore Politi,
  • Arturo Chiti,
  • Luca Balzarini,
  • Alessio Aghemo and
  • Luca Viganò
  • + 3 authors

20 June 2021

Non-invasive diagnosis of chemotherapy-associated liver injuries (CALI) is still an unmet need. The present study aims to elucidate the contribution of radiomics to the diagnosis of sinusoidal dilatation (SinDil), nodular regenerative hyperplasia (NR...

  • Review
  • Open Access
66 Citations
13,235 Views
43 Pages

20 June 2021

The ubiquitin-proteasome system (UPS) is a critical regulator of cellular protein levels and activity. It is, therefore, not surprising that its dysregulation is implicated in numerous human diseases, including many types of cancer. Moreover, since c...

  • Article
  • Open Access
6 Citations
5,248 Views
15 Pages

Myeloid-Specific Acly Deletion Alters Macrophage Phenotype In Vitro and In Vivo without Affecting Tumor Growth

  • Kyra E. de Goede,
  • Sanne G. S. Verberk,
  • Jeroen Baardman,
  • Karl J. Harber,
  • Yvette van Kooyk,
  • Menno P. J. de Winther,
  • Sjoerd T. T. Schetters and
  • Jan Van den Bossche

19 June 2021

Cancer cells rely on ATP-citrate lyase (Acly)-derived acetyl-CoA for lipid biogenesis and proliferation, marking Acly as a promising therapeutic target. However, inhibitors may have side effects on tumor-associated macrophages (TAMs). TAMs are innate...

  • Review
  • Open Access
51 Citations
9,622 Views
22 Pages

19 June 2021

Chromosomal instability (CIN) refers to an increased rate of acquisition of numerical and structural changes in chromosomes and is considered an enabling characteristic of tumors. Given its role as a facilitator of genomic changes, CIN is increasingl...

  • Article
  • Open Access
9 Citations
3,746 Views
23 Pages

19 June 2021

Tumor-associated macrophages (TAMs) plentifully infiltrate the tumor microenvironment (TME), but their role in anti-tumor immunity is controversial. Depending on the acquired polarization, they can either support tumor growth or participate in the el...

  • Article
  • Open Access
20 Citations
5,337 Views
21 Pages

Dual Role of Integrin Alpha-6 in Glioblastoma: Supporting Stemness in Proneural Stem-Like Cells While Inducing Radioresistance in Mesenchymal Stem-Like Cells

  • Elisabetta Stanzani,
  • Leire Pedrosa,
  • Guillaume Bourmeau,
  • Oceane Anezo,
  • Aleix Noguera-Castells,
  • Anna Esteve-Codina,
  • Lorena Passoni,
  • Michela Matteoli,
  • Núria de la Iglesia and
  • Avelina Tortosa
  • + 2 authors

19 June 2021

Therapeutic resistance after multimodal therapy is the most relevant cause of glioblastoma (GBM) recurrence. Extensive cellular heterogeneity, mainly driven by the presence of GBM stem-like cells (GSCs), strongly correlates with patients’ prognosis a...

  • Feature Paper
  • Review
  • Open Access
17 Citations
4,364 Views
14 Pages

Structure vs. Function of TRIB1—Myeloid Neoplasms and Beyond

  • Hamish D McMillan,
  • Karen Keeshan,
  • Anita K Dunbier and
  • Peter D Mace

19 June 2021

The Tribbles family of proteins—comprising TRIB1, TRIB2, TRIB3 and more distantly related STK40—play important, but distinct, roles in differentiation, development and oncogenesis. Of the four Tribbles proteins, TRIB1 has been most well characterised...

  • Systematic Review
  • Open Access
26 Citations
3,972 Views
14 Pages

Microbiota Alterations in Precancerous Colon Lesions: A Systematic Review

  • Francesca Aprile,
  • Giovanni Bruno,
  • Rossella Palma,
  • Maria Teresa Mascellino,
  • Cristina Panetta,
  • Giulia Scalese,
  • Alessandra Oliva,
  • Carola Severi and
  • Stefano Pontone

19 June 2021

Gut microbiota plays an important role in human health. It may promote carcinogenesis and is related to several diseases of the gastrointestinal tract. This study of microbial dysbiosis in the etiology of colorectal adenoma aimed to investigate the p...

  • Article
  • Open Access
15 Citations
3,974 Views
18 Pages

Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo

  • Barbara Schwertner,
  • Georg Lindner,
  • Camila Toledo Stauner,
  • Elisa Klapproth,
  • Clara Magnus,
  • Anette Rohrhofer,
  • Stefanie Gross,
  • Beatrice Schuler-Thurner,
  • Veronika Öttl and
  • Sebastian Haferkamp
  • + 7 authors

19 June 2021

Talimogene laherparepvec (T-VEC), an oncolytic herpes simplex virus, is approved for intralesional injection of unresectable stage IIIB/IVM1a melanoma. However, it is still unclear which parameter(s) predict treatment response or failure. Our study a...

  • Article
  • Open Access
29 Citations
4,894 Views
12 Pages

Diagnostic Yield of Endoscopic Ultrasound-Guided Liver Biopsy in Comparison to Percutaneous Liver Biopsy: A Two-Center Experience

  • Antonio Facciorusso,
  • Daryl Ramai,
  • Maria Cristina Conti Bellocchi,
  • Laura Bernardoni,
  • Erminia Manfrin,
  • Nicola Muscatiello and
  • Stefano Francesco Crinò

19 June 2021

There is scarce and conflicting evidence on the comparison between endoscopic ultrasound (EUS) and percutaneous (PC)-guided liver biopsy (LB). The aim of this study was to compare the two approaches in a series of patients with parenchymal and focal...

  • Review
  • Open Access
51 Citations
7,003 Views
18 Pages

19 June 2021

A defect in the DNA repair system through a deficient mismatch repair system (dMMR) leads to microsatellite instability (MSI). Microsatellites are located in both coding and non-coding sequences and dMMR/MSI tumors are associated with a high mutation...

  • Article
  • Open Access
14 Citations
4,612 Views
9 Pages

Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality

  • Jean-Emmanuel Bibault,
  • Steven Hancock,
  • Mark K. Buyyounouski,
  • Hilary Bagshaw,
  • John T. Leppert,
  • Joseph C. Liao and
  • Lei Xing

19 June 2021

Prostate cancer treatment strategies are guided by risk-stratification. This stratification can be difficult in some patients with known comorbidities. New models are needed to guide strategies and determine which patients are at risk of prostate can...

  • Review
  • Open Access
69 Citations
12,697 Views
39 Pages

19 June 2021

Forkhead box M1 (FOXM1) is a member of the conserved forkhead box (FOX) transcription factor family. Over the last two decades, FOXM1 has emerged as a multifunctional oncoprotein and a robust biomarker of poor prognosis in many human malignancies. In...

  • Review
  • Open Access
23 Citations
5,308 Views
13 Pages

Understanding the Clinical Impact of MUC5AC Expression on Pancreatic Ductal Adenocarcinoma

  • Ashish Manne,
  • Ashwini Esnakula,
  • Laith Abushahin and
  • Allan Tsung

19 June 2021

Mucin-5AC (MUC5AC) is a heavily glycosylated gel-forming secreted mucin with a reliable prognostic value when detected in multiple malignancies. It is highly prevalent (70%) in PDA and is nonexistent in normal pancreatic tissues. Retrospective studie...

  • Review
  • Open Access
17 Citations
3,975 Views
14 Pages

19 June 2021

Altered cell metabolism is a hallmark of cancer cell biology, and the adaptive metabolic strategies of cancer cells have been of recent interest to many groups. Metabolic reprogramming has been identified as a critical step in glial cell transformati...

  • Article
  • Open Access
12 Citations
3,557 Views
13 Pages

NGS-Based Analysis of Atypical Deep Penetrating Nevi

  • Antonella Manca,
  • Maria Cristina Sini,
  • Anna Maria Cesinaro,
  • Francesca Portelli,
  • Carmelo Urso,
  • Maria Lentini,
  • Roberta Cardia,
  • Llucia Alos,
  • Martin Cook and
  • Daniela Massi
  • + 5 authors

19 June 2021

Deep penetrating nevi (DPNs) are rare melanocytic neoplasms consisting of pigmented spindled or epithelioid melanocytes with a distinctive wedge-shaped configuration showing activation of the WNT pathway, with unusual cyto-architectural features. It...

  • Article
  • Open Access
16 Citations
7,842 Views
19 Pages

Survival Outcomes in Invasive Lobular Carcinoma Compared to Oestrogen Receptor-Positive Invasive Ductal Carcinoma

  • Jasmine Timbres,
  • Charlotte Moss,
  • Anca Mera,
  • Anna Haire,
  • Cheryl Gillett,
  • Mieke Van Hemelrijck and
  • Elinor Sawyer

18 June 2021

Invasive lobular breast cancer (ILC) accounts for 10–15% of breast cancers and has distinct characteristics compared with the more common invasive ductal carcinoma (IDC). Studies have shown that ILC may be less sensitive to chemotherapy than IDC, wit...

  • Article
  • Open Access
11 Citations
3,985 Views
23 Pages

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma

  • Mickaël Burgy,
  • Aude Jehl,
  • Ombline Conrad,
  • Sophie Foppolo,
  • Véronique Bruban,
  • Nelly Etienne-Selloum,
  • Alain C. Jung,
  • Murielle Masson,
  • Christine Macabre and
  • Sophie Martin
  • + 10 authors

18 June 2021

The EGFR-targeting antibody cetuximab (CTX) combined with radiotherapy is the only targeted therapy that has been proven effective for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Recurrence arises in 50% of pat...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694